DEVAKI SHRESTHA: Open Payments
NPI 1811681851 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 15 payments from 11 companies in 2025. Trend: 2023 $406 · 2024 $495 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $192 |
| Abbott Laboratories | 1 | $138 |
| ARGENX US, INC. | 1 | $116 |
| Novo Nordisk Inc | 1 | $116 |
| Paratek Pharmaceuticals, Inc. | 1 | $114 |
| SANOFI PASTEUR INC. | 1 | $103 |
| PFIZER INC. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| SI-BONE, INC. | 1 | $23 |
Products named: DEXCOM G7 GSS (161), THORATEC HEARTMATE 3 LVAS IMPLANT KIT, VYVGART, Ozempic, NUZYRA, ELIQUIS, TRELEGY ELLIPTA, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
